PDCD1 polymorphisms are not associated with Takayasu's arteritis in Turkey


Direskeneli H., Tuna-Erdoǧan E., Gündüz F., Bandurska-Luque A., Alparslan B., Kebe M., ...Daha Fazla

Clinical and Experimental Rheumatology, cilt.30, sa.SUPPL. 70, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: SUPPL. 70
  • Basım Tarihi: 2012
  • Dergi Adı: Clinical and Experimental Rheumatology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Takayasu's arteritis, PDCD1, programmed cell death, RHEUMATOID-ARTHRITIS, GENE POLYMORPHISM, ANKYLOSING-SPONDYLITIS, SUSCEPTIBILITY, CELLS, PD-1, EXPRESSION, DISEASE, ALLELE, TISSUE
  • Ankara Üniversitesi Adresli: Evet

Özet

Objectives: Takayasu's arteritis (TA) is a chronic arterial inflammation of unknown etiology involving mainly the aorta and its major branches. Based on the associations of programmed death-1 (PD-1) protein encoding gene (PDCD1) with connective tissue diseases and vasculitides, PDCD1 polymorphisms are studied for susceptibility to TA in this study. Methods: The study group is made up of TA patients (n=229) fulfilling the 1990 ACR classification criteria and compared to 193 healthy controls (HC). PD-1.3, PD-1.5 and PD-1.6 single nucleotide polymorphisms of PDCD1 gene are genotyped by polymerase chain reaction and restriction analysis (PCR-RFLP). Results: The distribution of PD-1.5 polymorphism in TA patients and HC revealed a similar presence of TT genotype in patients and controls (13.3% vs. 11.4%). PD-1.3 and PD-1.6 were less polymorphic and did not differ between the groups. Rare AA genotype of PD-1.3 (1.4% vs. 1.0%) and AG genotype of PD-1.6 was again similarly (22.4% vs. 19.2%) present in TA and HC. Conclusion: PD-1.3, 1.5 and 1.6 polymorphisms of PDCD1 gene, which were shown to be associated with various autoimmune disorders and vasculitides, are not associated with a susceptibility to TA in Turkish population. © Clinical and Experimental Rheumatology 2012.